Bioneer Corporation (KOSDAQ:064550)

South Korea · Delayed Price · Currency is KRW

11,000

+2,210 (25.14%)

Sep 1, 2026, 3:30 PM KST

-21.76% (1Y)

Market Cap	283.91B -21.8%
Revenue (ttm)	345.88B +15.9%
Net Income	-6.67B
EPS	-257.51
Shares Out	25.81M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,573,043
Open	9,060
Previous Close	8,790
Day's Range	8,720 - 11,300
52-Week Range	5,470 - 15,640
Beta	0.37
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2026

About Bioneer

Bioneer Corporation operates as a biotechnology company in South Korea, the Americas, Europe, Asia, Africa, and internationally. The company offers PCR and RT-PCR, real-time PCR, RNAi, chemicals, plastic consumables, and buffer and solutions; and sample preparation, protein synthesis and purification, gene cloning, fluorescence dye and quencher, electrophoresis, genome-wide function, and magnetic separation services, as well as instruments for conventional PCR, real-time PCR, sample preparation, protein synthesis, centrifuge and vortex mixer, a... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 1992

Employees 392

Stock Exchange KOSDAQ

Ticker Symbol 064550

Full Company Profile

Financial Performance

In 2025, Bioneer's revenue was 330.11 billion, an increase of 12.29% compared to the previous year's 293.98 billion. Losses were -2.81 billion, -86.33% less than in 2024.

Financial Statements